| 000 | 01767 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250516115354.0 | ||
| 264 | 0 | _c20130529 | |
| 008 | 201305s 0 0 eng d | ||
| 022 | _a1460-2350 | ||
| 024 | 7 |
_a10.1093/humrep/des369 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRicci, A G | |
| 245 | 0 | 0 |
_aNatural therapies assessment for the treatment of endometriosis. _h[electronic resource] |
| 260 |
_bHuman reproduction (Oxford, England) _cJan 2013 |
||
| 300 |
_a178-88 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAngiogenesis Inhibitors _xadministration & dosage |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntioxidants _xadministration & dosage |
| 650 | 0 | 4 |
_aApoptosis _xdrug effects |
| 650 | 0 | 4 |
_aCatechin _xadministration & dosage |
| 650 | 0 | 4 | _aCell Proliferation |
| 650 | 0 | 4 | _aCells, Cultured |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 |
_aEndometriosis _xdrug therapy |
| 650 | 0 | 4 |
_aEndometrium _xblood supply |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInjections, Intraperitoneal |
| 650 | 0 | 4 |
_aIntestinal Diseases _xdrug therapy |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Inbred BALB C |
| 650 | 0 | 4 |
_aNeovascularization, Pathologic _xetiology |
| 650 | 0 | 4 | _aRandom Allocation |
| 650 | 0 | 4 | _aResveratrol |
| 650 | 0 | 4 |
_aStilbenes _xadministration & dosage |
| 700 | 1 | _aOlivares, C N | |
| 700 | 1 | _aBilotas, M A | |
| 700 | 1 | _aBastón, J I | |
| 700 | 1 | _aSingla, J J | |
| 700 | 1 | _aMeresman, G F | |
| 700 | 1 | _aBarañao, R I | |
| 773 | 0 |
_tHuman reproduction (Oxford, England) _gvol. 28 _gno. 1 _gp. 178-88 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1093/humrep/des369 _zAvailable from publisher's website |
| 999 |
_c22197284 _d22197284 |
||